NCT07378488 Dance/Movement Therapy for Functional Neurological Disorder
| NCT ID | NCT07378488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King's College London |
| Condition | Functional Neurological Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-28 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-01-28 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Building on evidence for somatic or physical interventions in functional neurological disorder (FND), the goal of this study is to test the feasibility of a structured dance/movement task in individuals with FND, and explore the potential use of somatic or body-based therapies in this population. The primary study outcomes will be the feasibility and acceptability of a structured dance/movement therapy (DMT) intervention for individuals diagnosed with FND. The study will also explore whether this type of intervention has potential to contribute to elevating trust in the body and general wellbeing, alongside reducing functional neurological and dissociative symptoms. Researchers will compare structured dance/movement therapy to a physical exercise/body coordination condition.
Eligibility Criteria
Inclusion Criteria: * Aged 18 or older * Fluency in English language * Normal or corrected eyesight * Primary diagnosis of FND with seizures, motor symptoms, sensory symptoms, or mixed FND symptoms * Participants will be asked to provide proof of FND diagnosis in the form of an existing medical letter from a qualified healthcare professional (not required to be from an NHS service). This will be checked prior to engaging in the screening interview for the study. Exclusion Criteria: * Physical symptoms or disability that would prohibit the participant's ability to engage with the intervention and/or attend the in-person sessions (e.g., upper/lower limb paralysis, seizure frequency \> 10 per day, severe tremor) * A diagnosis of functional cognitive disorder or functional cognitive symptoms only * Current participation in another body-based therapy or intervention for FND - participants currently engaging in some form of body- based therapy, whether self-guided or therapist-guided, will be asked to abstain from these sessions during the course of this study. If this is not feasible, the participant will be excluded from the current study. * Current comorbid diagnosis of a major neurological (e.g., epilepsy, Parkinson's), psychiatric (e.g., schizophrenia, active psychosis, severe alcohol or substance use disorder), or cardiovascular (e.g., coronary artery disease, heart failure) disorder that may impair the participant's ability to participate in the study and confound the results
Frequently Asked Questions
Who can join the NCT07378488 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Functional Neurological Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07378488 currently recruiting?
Yes, NCT07378488 is actively recruiting participants. Visit ClinicalTrials.gov or contact King's College London to inquire about joining.
Where is the NCT07378488 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT07378488 clinical trial?
NCT07378488 is sponsored by King's College London. The trial plans to enroll 30 participants.